SCOTLANDI, KATIA
SCOTLANDI, KATIA
ARAG - AREA FINANZA E CONTABILITA'
Collaboratori
CD99 contributes to the EWS::FLI1 transcriptome by specifically affecting FOXM1-targets involved in the G2/M cell cycle phase, thus influencing the Ewing sarcoma genetic landscape
2024 Pasello M.; Laginestra M.A.; Manara M.C.; Landuzzi L.; Ruzzi F.; Maioli M.; Pellegrini E.; De Feo A.; Lollini P.-L.; Scotlandi K.
IDH mutations in G2-3 conventional central bone chondrosarcoma: a mono institutional experience
2023 Setola, Elisabetta; Benini, S; Righi, A; Gamberi, G; Carretta, E; Ferrari, C; Avnet, S; Palmerini, E; Magagnoli, G; Gambarotti, M; Lollini, P L; Cesari, M; Cocchi, S; Paioli, A; Longhi, A; Scotlandi, K; Laginestra, M A; Donati, D M; Baldini, N; Ibrahim, T
Innovative Breakthroughs for the Treatment of Advanced and Metastatic Synovial Sarcoma
2023 Landuzzi L.; Manara M.C.; Pazzaglia L.; Lollini P.L.; Scotlandi K.
Synovial Sarcoma Preclinical Modeling: Integrating Transgenic Mouse Models and Patient-Derived Models for Translational Research
2023 Lorena Landuzzi, Francesca Ruzzi, Pier-Luigi Lollini, Katia Scotlandi
ABCA6 affects the malignancy of Ewing sarcoma cells via cholesterol-guided inhibition of the IGF1R/AKT/MDM2 axis
2022 Pasello, Michela; Giudice, Anna Maria; Cristalli, Camilla; Manara, Maria Cristina; Mancarella, Caterina; Parra, Alessandro; Serra, Massimo; Magagnoli, Giovanna; Cidre-Aranaz, Florencia; Grünewald, Thomas G P; Bini, Carla; Lollini, Pier-Luigi; Longhi, Alessandra; Donati, Davide Maria; Scotlandi, Katia
Bone Turnover Marker (BTM) Changes after Denosumab in Giant Cell Tumors of Bone (GCTB): A Phase II Trial Correlative Study
2022 Palmerini E.; Pazzaglia L.; Cevolani L.; Pratelli L.; Pierini M.; Quattrini I.; Carretta E.; Manara M.C.; Pasello M.; Frega G.; Paioli A.; Longhi A.; Cesari M.; Hakim R.; Ibrahim T.; Campanacci L.; Staals E.L.; Donati D.M.; Benassi M.S.; Scotlandi K.; Ferrari S.
Combined Treatment with PI3K Inhibitors BYL-719 and CAL-101 Is a Promising Antiproliferative Strategy in Human Rhabdomyosarcoma Cells
2022 Manuela Piazzi; Alberto Bavelloni; Vittoria Cenni; Sara Salucci; Anna Bartoletti Stella; Enrica Tomassini; Katia Scotlandi; William L. Blalock; Irene Faenza
Correction to: ABCA6 affects the malignancy of Ewing sarcoma cells via cholesterol-guided inhibition of the IGF1R/AKT/MDM2 axis
2022 Pasello, Michela; Giudice, Anna Maria; Cristalli, Camilla; Manara, Maria Cristina; Mancarella, Caterina; Parra, Alessandro; Serra, Massimo; Magagnoli, Giovanna; Cidre-Aranaz, Florencia; Grünewald, Thomas G P; Bini, Carla; Lollini, Pier-Luigi; Longhi, Alessandra; Donati, Davide Maria; Scotlandi, Katia
Corrigendum to “SELNET clinical practice guidelines for bone sarcoma” Critical reviews in oncology/hematology, vol. 174 (2022), 1–10 (Critical Reviews in Oncology / Hematology (2022) 174, (S1040842822001093), (10.1016/j.critrevonc.2022.103685))
2022 Blay J.Y.; Palmerini E.; Bollard J.; Aguiar S.; Angel M.; Araya B.; Badilla R.; Bernabeu D.; Campos F.; Chs C.-S.; Carvajal Montoya A.; Casavilca-Zambrano S.; Castro-Oliden; Chacon M.; Clara-Altamirano M.A.; Collini P.; Correa Genoroso R.; Costa F.D.; Cuellar M.; Dei Tos A.P.; Dominguez Malagon H.R.; Donati D.M.; Dufresne A.; Eriksson M.; Farias-Loza M.; Frezza A.M.; Frisoni T.; Garcia-Ortega D.Y.; Gerderblom H.; Gouin F.; Gomez-Mateo M.C.; Gronchi A.; Haro J.; Hindi N.; Huanca L.; Jimenez N.; Karanian M.; Kasper B.; Lopes A.; Lopes David B.B.; Lopez-Pousa A.; Lutter G.; Maki R.G.; Martinez-Said H.; Martinez-Tlahuel J.L.; Mello C.A.; Morales Perez J.M.; Moura D.S.; Nakagawa S.A.; Nascimento A.G.; Ortiz-Cruz E.J.; Patel S.; Pfluger Y.; Provenzano S.; Righi A.; Rodriguez A.; Santos T.G.; Scotlandi K.; Mlg S.; Soule T.; Stacchiotti S.; Valverde C.M.; Waisberg F.; Zamora Estrada E.; Martin-Broto J.
Integrated molecular characterization of patient-derived models reveals therapeutic strategies for treating CIC-DUX4 sarcoma
2022 Carrabotta, Marianna; Laginestra, Maria Antonella; Durante, Giorgio; Mancarella, Caterina; Landuzzi, Lorena; Parra, Alessandro; Ruzzi, Francesca; Toracchio, Lisa; De Feo, Alessandra; Giusti, Veronica; Pasello, Michela; Righi, Alberto; Lollini, Pier-Luigi; Palmerini, Emanuela; Donati, Davide Maria; Manara, Maria Cristina; Scotlandi, Katia
Lamin A and the LINC complex act as potential tumor suppressors in Ewing Sarcoma
2022 Chiarini, Francesca; Paganelli, Francesca; Balestra, Tommaso; Capanni, Cristina; Fazio, Antonietta; Manara, Maria Cristina; Landuzzi, Lorena; Petrini, Stefania; Evangelisti, Camilla; Lollini, Pier-Luigi; Martelli, Alberto M.; Lattanzi, Giovanna; Scotlandi, Katia
Phase 2 study for nonmetastatic extremity high-grade osteosarcoma in pediatric and adolescent and young adult patients with a risk-adapted strategy based on ABCB1/P-glycoprotein expression: An Italian Sarcoma Group trial (ISG/OS-2)
2022 Palmerini E.; Meazza C.; Tamburini A.; Bisogno G.; Ferraresi V.; Asaftei S.D.; Milano G.M.; Coccoli L.; Manzitti C.; Luksch R.; Serra M.; Gambarotti M.; Donati D.M.; Scotlandi K.; Bertulli R.; Favre C.; Longhi A.; Abate M.E.; Perrotta S.; Mascarin M.; D'Angelo P.; Cesari M.; Staals E.L.; Marchesi E.; Carretta E.; Ibrahim T.; Casali P.G.; Picci P.; Fagioli F.; Ferrari S.
Polymorphic variants of IGF2BP3 and SENCR have an impact on predisposition and/or progression of Ewing sarcoma
2022 Martinelli, Marcella; Mancarella, Caterina; Scapoli, Luca; Palmieri, Annalisa; De Sanctis, Paola; Ferrari, Cristina; Pasello, Michela; Zucchini, Cinzia; Scotlandi, Katia
SELNET clinical practice guidelines for bone sarcoma
2022 Blay, JY; Palmerini, E.; Bollard, J.; Aguiar, S.; Angel, M.; Araya, B.; Badilla, R.; Bernabeu, D.; Campos, F.; CHS, Caro-Sánchez; Carvajal Montoya, A.; Casavilca-Zambrano, S.; Castro-Oliden, null; Chacón, M.; Clara-Altamirano, MA; Collini, P.; Correa Genoroso, R.; Costa, FD; Cuellar, M.; dei Tos, AP; Dominguez Malagon, HR; Donati, DM; Dufresne, A.; Eriksson, M.; Farias-Loza, M.; Frezza, AM; Frisoni, T.; Garcia-Ortega, DY; Gerderblom, H.; Gouin, F.; Gómez-Mateo, MC; Gronchi, A.; Haro, J.; Hindi, N.; Huanca, L.; Jimenez, N.; Karanian, M.; Kasper, B.; Lopes, A.; Lopes David, BB; Lopez-Pousa, A.; Lutter, G.; Maki, RG; Martinez-Said, H.; Martinez-Tlahuel, JL; Mello, CA; Morales Pérez, JM; Moura, DS; Nakagawa, SA; Nascimento, AG; Ortiz-Cruz, EJ; Patel, S.; Pfluger, Y.; Provenzano, S.; Righi, A.; Rodriguez, A.; Santos, TG; Scotlandi, K.; MLG, Silva; Soulé, T.; Stacchiotti, S.; Valverde, CM; Waisberg, F.; Zamora Estrada, E.; Martin-Broto, J.
SELNET clinical practice guidelines for soft tissue sarcoma and GIST
2022 Blay, J.Y.; Hindi, N.; Bollard, J.; Aguiar, S.; Angel, M.; Araya, B.; Badilla, R.; Bernabeu, D.; Campos, F.; Caro-Sánchez, C.H.S.; Carvajal, B.; Carvajal Montoya, A.; Casavilca-Zambrano, S.; Castro-Oliden, V.; Chacón, M.; Clara, M.; Collini, P.; Correa Genoroso, R.; Costa, F.D.; Cuellar, M.; dei Tos, A.P.; Dominguez Malagon, H.R.; Donati, D.; Dufresne, A.; Eriksson, M.; Farias-Loza, M.; Fernandez, P.; Frezza, A.M.; Frisoni, T.; Garcia-Ortega, D.Y.; Gelderblom, H.; Gouin, F.; Gómez-Mateo, M.C.; Gronchi, A.; Haro, J.; Huanca, L.; Jimenez, N.; Karanian, M.; Kasper, B.; Lopes David, B.B.; Lopez-Pousa, A.; Lutter, G.; Martinez-Said, H.; Martinez-Tlahuel, J.; Mello, C.A.; Morales Pérez, J.M.; Moura David, S.; Nascimento, A.G.; Ortiz-Cruz, E.J.; Palmerini, E.; Patel, S.; Pfluger, Y.; Provenzano, S.; Righi, A.; Rodriguez, A.; Salas, R.; Santos, T.T.G.; Scotlandi, K.; Soule, T.; Stacchiotti, S.; Valverde, C.; Waisberg, F.; Zamora Estrada, E.; Martin-Broto, J.
Targeting CD99 compromises the oncogenic effects of the chimera EWS-FLI1 by inducing re-expression of zyxin and inhibition of Gli1 activity
2022 Balestra, Tommaso; Manara, Maria Cristina; Laginestra, Maria Antonella; Pasello, Michela; De Feo, Alessandra; Bassi, Cristian; Guerzoni, Clara; Landuzzi, Lorena; Lollini, Pier-Luigi; Donati, Davide Maria; Negrini, Massimo; Magnani, Mauro; Scotlandi, Katia
Patient Derived Xenografts for Genome-Driven Therapy of Osteosarcoma
2021 Landuzzi, Lorena; Manara, Maria Cristina; Lollini, Pier-Luigi; Scotlandi, Katia
Sunitinib Exerts In Vitro Immunomodulatory Activity on Sarcomas via Dendritic Cells and Synergizes With PD-1 Blockade
2021 Ocadlikova D.; Lecciso M.; Broto J.M.; Scotlandi K.; Cavo M.; Curti A.; Palmerini E.
Circulating miR34a levels as a potential biomarker in the follow-up of Ewing sarcoma
2020 Sciandra M.; De Feo A.; Parra A.; Landuzzi L.; Lollini P.-L.; Manara M.C.; Mattia G.; Pontecorvi G.; Baricordi C.; Guerzoni C.; Bazzocchi A.; Longhi A.; Scotlandi K.
Insulin-Like Growth Factor 2 mRNA-Binding Protein 3 Modulates Aggressiveness of Ewing Sarcoma by Regulating the CD164-CXCR4 Axis
2020 Caterina Mancarella , Giulia Caldoni, Irene Ribolsi, Alessandro Parra , Maria Cristina Manara , Arthur M Mercurio , Andrea Morrione , Katia Scotlandi
| Titolo | Autore(i) | Anno | Periodico | Editore | Tipo | File |
|---|---|---|---|---|---|---|
| CD99 contributes to the EWS::FLI1 transcriptome by specifically affecting FOXM1-targets involved in the G2/M cell cycle phase, thus influencing the Ewing sarcoma genetic landscape | Pasello M.; Laginestra M.A.; Manara M.C.; Landuzzi L.; Ruzzi F.; Maioli M.; Pellegrini E.; De Feo... A.; Lollini P.-L.; Scotlandi K. | 2024-01-01 | JOURNAL OF CELL COMMUNICATION AND SIGNALING | - | 1.01 Articolo in rivista | Journal of Cell Communication and Signaling - 2024 - Pasello - CD99 contributes to the EWS FLI1 transcriptome by.pdf |
| IDH mutations in G2-3 conventional central bone chondrosarcoma: a mono institutional experience | Setola, Elisabetta; Benini, S; Righi, A; Gamberi, G; Carretta, E; Ferrari, C; Avnet, S; Palmerini..., E; Magagnoli, G; Gambarotti, M; Lollini, P L; Cesari, M; Cocchi, S; Paioli, A; Longhi, A; Scotlandi, K; Laginestra, M A; Donati, D M; Baldini, N; Ibrahim, T | 2023-01-01 | BMC CANCER | - | 1.01 Articolo in rivista | Setola Chondrosarcomapdf.pdf |
| Innovative Breakthroughs for the Treatment of Advanced and Metastatic Synovial Sarcoma | Landuzzi L.; Manara M.C.; Pazzaglia L.; Lollini P.L.; Scotlandi K. | 2023-01-01 | CANCERS | - | 1.01 Articolo in rivista | Synovial review 2 cancers-15-03887-v3.pdf |
| Synovial Sarcoma Preclinical Modeling: Integrating Transgenic Mouse Models and Patient-Derived Models for Translational Research | Lorena Landuzzi, Francesca Ruzzi, Pier-Luigi Lollini, Katia Scotlandi | 2023-01-01 | CANCERS | - | 1.01 Articolo in rivista | Synovial cancers-15-00588.pdf |
| ABCA6 affects the malignancy of Ewing sarcoma cells via cholesterol-guided inhibition of the IGF1R/AKT/MDM2 axis | Pasello, Michela; Giudice, Anna Maria; Cristalli, Camilla; Manara, Maria Cristina; Mancarella, Ca...terina; Parra, Alessandro; Serra, Massimo; Magagnoli, Giovanna; Cidre-Aranaz, Florencia; Grünewald, Thomas G P; Bini, Carla; Lollini, Pier-Luigi; Longhi, Alessandra; Donati, Davide Maria; Scotlandi, Katia | 2022-01-01 | CELLULAR ONCOLOGY | - | 1.01 Articolo in rivista | ABCA6 Cellular Oncology.pdf; 13402_2022_713_MOESM9_ESM.zip |
| Bone Turnover Marker (BTM) Changes after Denosumab in Giant Cell Tumors of Bone (GCTB): A Phase II Trial Correlative Study | Palmerini E.; Pazzaglia L.; Cevolani L.; Pratelli L.; Pierini M.; Quattrini I.; Carretta E.; Mana...ra M.C.; Pasello M.; Frega G.; Paioli A.; Longhi A.; Cesari M.; Hakim R.; Ibrahim T.; Campanacci L.; Staals E.L.; Donati D.M.; Benassi M.S.; Scotlandi K.; Ferrari S. | 2022-01-01 | CANCERS | - | 1.01 Articolo in rivista | cancers-14-02863-v2 (1).pdf |
| Combined Treatment with PI3K Inhibitors BYL-719 and CAL-101 Is a Promising Antiproliferative Strategy in Human Rhabdomyosarcoma Cells | Manuela Piazzi; Alberto Bavelloni; Vittoria Cenni; Sara Salucci; Anna Bartoletti Stella; Enrica T...omassini; Katia Scotlandi; William L. Blalock; Irene Faenza | 2022-01-01 | MOLECULES | - | 1.01 Articolo in rivista | molecules-27-02742.pdf |
| Correction to: ABCA6 affects the malignancy of Ewing sarcoma cells via cholesterol-guided inhibition of the IGF1R/AKT/MDM2 axis | Pasello, Michela; Giudice, Anna Maria; Cristalli, Camilla; Manara, Maria Cristina; Mancarella, Ca...terina; Parra, Alessandro; Serra, Massimo; Magagnoli, Giovanna; Cidre-Aranaz, Florencia; Grünewald, Thomas G P; Bini, Carla; Lollini, Pier-Luigi; Longhi, Alessandra; Donati, Davide Maria; Scotlandi, Katia | 2022-01-01 | CELLULAR ONCOLOGY | - | 1.01 Articolo in rivista | s13402-022-00735-z.pdf |
| Corrigendum to “SELNET clinical practice guidelines for bone sarcoma” Critical reviews in oncology/hematology, vol. 174 (2022), 1–10 (Critical Reviews in Oncology / Hematology (2022) 174, (S1040842822001093), (10.1016/j.critrevonc.2022.103685)) | Blay J.Y.; Palmerini E.; Bollard J.; Aguiar S.; Angel M.; Araya B.; Badilla R.; Bernabeu D.; Camp...os F.; Chs C.-S.; Carvajal Montoya A.; Casavilca-Zambrano S.; Castro-Oliden; Chacon M.; Clara-Altamirano M.A.; Collini P.; Correa Genoroso R.; Costa F.D.; Cuellar M.; Dei Tos A.P.; Dominguez Malagon H.R.; Donati D.M.; Dufresne A.; Eriksson M.; Farias-Loza M.; Frezza A.M.; Frisoni T.; Garcia-Ortega D.Y.; Gerderblom H.; Gouin F.; Gomez-Mateo M.C.; Gronchi A.; Haro J.; Hindi N.; Huanca L.; Jimenez N.; Karanian M.; Kasper B.; Lopes A.; Lopes David B.B.; Lopez-Pousa A.; Lutter G.; Maki R.G.; Martinez-Said H.; Martinez-Tlahuel J.L.; Mello C.A.; Morales Perez J.M.; Moura D.S.; Nakagawa S.A.; Nascimento A.G.; Ortiz-Cruz E.J.; Patel S.; Pfluger Y.; Provenzano S.; Righi A.; Rodriguez A.; Santos T.G.; Scotlandi K.; Mlg S.; Soule T.; Stacchiotti S.; Valverde C.M.; Waisberg F.; Zamora Estrada E.; Martin-Broto J. | 2022-01-01 | CRITICAL REVIEWS IN ONCOLOGY HEMATOLOGY | - | 1.01 Articolo in rivista | - |
| Integrated molecular characterization of patient-derived models reveals therapeutic strategies for treating CIC-DUX4 sarcoma | Carrabotta, Marianna; Laginestra, Maria Antonella; Durante, Giorgio; Mancarella, Caterina; Landuz...zi, Lorena; Parra, Alessandro; Ruzzi, Francesca; Toracchio, Lisa; De Feo, Alessandra; Giusti, Veronica; Pasello, Michela; Righi, Alberto; Lollini, Pier-Luigi; Palmerini, Emanuela; Donati, Davide Maria; Manara, Maria Cristina; Scotlandi, Katia | 2022-01-01 | CANCER RESEARCH | - | 1.01 Articolo in rivista | CIC-DUX4 Cancer Res 2022.pdf; can-21-1222_supplementary_data_supp1-9.pdf; can-21-1222_supplementary_methods_and_figures_supp1-13.pdf |
| Lamin A and the LINC complex act as potential tumor suppressors in Ewing Sarcoma | Chiarini, Francesca; Paganelli, Francesca; Balestra, Tommaso; Capanni, Cristina; Fazio, Antoniett...a; Manara, Maria Cristina; Landuzzi, Lorena; Petrini, Stefania; Evangelisti, Camilla; Lollini, Pier-Luigi; Martelli, Alberto M.; Lattanzi, Giovanna; Scotlandi, Katia | 2022-01-01 | CELL DEATH & DISEASE | - | 1.01 Articolo in rivista | Lamin Cell Death Dis.pdf; 41419_2022_4729_MOESM1_ESM.pdf |
| Phase 2 study for nonmetastatic extremity high-grade osteosarcoma in pediatric and adolescent and young adult patients with a risk-adapted strategy based on ABCB1/P-glycoprotein expression: An Italian Sarcoma Group trial (ISG/OS-2) | Palmerini E.; Meazza C.; Tamburini A.; Bisogno G.; Ferraresi V.; Asaftei S.D.; Milano G.M.; Cocco...li L.; Manzitti C.; Luksch R.; Serra M.; Gambarotti M.; Donati D.M.; Scotlandi K.; Bertulli R.; Favre C.; Longhi A.; Abate M.E.; Perrotta S.; Mascarin M.; D'Angelo P.; Cesari M.; Staals E.L.; Marchesi E.; Carretta E.; Ibrahim T.; Casali P.G.; Picci P.; Fagioli F.; Ferrari S. | 2022-01-01 | CANCER | - | 1.01 Articolo in rivista | Cancer - 2022 - Palmerini.pdf; cncr34131-sup-0002-tables1.zip |
| Polymorphic variants of IGF2BP3 and SENCR have an impact on predisposition and/or progression of Ewing sarcoma | Martinelli, Marcella; Mancarella, Caterina; Scapoli, Luca; Palmieri, Annalisa; De Sanctis, Paola;... Ferrari, Cristina; Pasello, Michela; Zucchini, Cinzia; Scotlandi, Katia | 2022-01-01 | FRONTIERS IN ONCOLOGY | - | 1.01 Articolo in rivista | articolo.pdf; Table 1.doc |
| SELNET clinical practice guidelines for bone sarcoma | Blay, JY; Palmerini, E.; Bollard, J.; Aguiar, S.; Angel, M.; Araya, B.; Badilla, R.; Bernabeu, D....; Campos, F.; CHS, Caro-Sánchez; Carvajal Montoya, A.; Casavilca-Zambrano, S.; Castro-Oliden, null; Chacón, M.; Clara-Altamirano, MA; Collini, P.; Correa Genoroso, R.; Costa, FD; Cuellar, M.; dei Tos, AP; Dominguez Malagon, HR; Donati, DM; Dufresne, A.; Eriksson, M.; Farias-Loza, M.; Frezza, AM; Frisoni, T.; Garcia-Ortega, DY; Gerderblom, H.; Gouin, F.; Gómez-Mateo, MC; Gronchi, A.; Haro, J.; Hindi, N.; Huanca, L.; Jimenez, N.; Karanian, M.; Kasper, B.; Lopes, A.; Lopes David, BB; Lopez-Pousa, A.; Lutter, G.; Maki, RG; Martinez-Said, H.; Martinez-Tlahuel, JL; Mello, CA; Morales Pérez, JM; Moura, DS; Nakagawa, SA; Nascimento, AG; Ortiz-Cruz, EJ; Patel, S.; Pfluger, Y.; Provenzano, S.; Righi, A.; Rodriguez, A.; Santos, TG; Scotlandi, K.; MLG, Silva; Soulé, T.; Stacchiotti, S.; Valverde, CM; Waisberg, F.; Zamora Estrada, E.; Martin-Broto, J. | 2022-01-01 | CRITICAL REVIEWS IN ONCOLOGY HEMATOLOGY | - | 1.01 Articolo in rivista | SELNET Bone CPGs.pdf |
| SELNET clinical practice guidelines for soft tissue sarcoma and GIST | Blay, J.Y.; Hindi, N.; Bollard, J.; Aguiar, S.; Angel, M.; Araya, B.; Badilla, R.; Bernabeu, D.; ...Campos, F.; Caro-Sánchez, C.H.S.; Carvajal, B.; Carvajal Montoya, A.; Casavilca-Zambrano, S.; Castro-Oliden, V.; Chacón, M.; Clara, M.; Collini, P.; Correa Genoroso, R.; Costa, F.D.; Cuellar, M.; dei Tos, A.P.; Dominguez Malagon, H.R.; Donati, D.; Dufresne, A.; Eriksson, M.; Farias-Loza, M.; Fernandez, P.; Frezza, A.M.; Frisoni, T.; Garcia-Ortega, D.Y.; Gelderblom, H.; Gouin, F.; Gómez-Mateo, M.C.; Gronchi, A.; Haro, J.; Huanca, L.; Jimenez, N.; Karanian, M.; Kasper, B.; Lopes David, B.B.; Lopez-Pousa, A.; Lutter, G.; Martinez-Said, H.; Martinez-Tlahuel, J.; Mello, C.A.; Morales Pérez, J.M.; Moura David, S.; Nascimento, A.G.; Ortiz-Cruz, E.J.; Palmerini, E.; Patel, S.; Pfluger, Y.; Provenzano, S.; Righi, A.; Rodriguez, A.; Salas, R.; Santos, T.T.G.; Scotlandi, K.; Soule, T.; Stacchiotti, S.; Valverde, C.; Waisberg, F.; Zamora Estrada, E.; Martin-Broto, J. | 2022-01-01 | CANCER TREATMENT REVIEWS | - | 1.01 Articolo in rivista | SELNET clinical practice guidelines for soft tissue sarcoma and GIST.pdf |
| Targeting CD99 compromises the oncogenic effects of the chimera EWS-FLI1 by inducing re-expression of zyxin and inhibition of Gli1 activity | Balestra, Tommaso; Manara, Maria Cristina; Laginestra, Maria Antonella; Pasello, Michela; De Feo,... Alessandra; Bassi, Cristian; Guerzoni, Clara; Landuzzi, Lorena; Lollini, Pier-Luigi; Donati, Davide Maria; Negrini, Massimo; Magnani, Mauro; Scotlandi, Katia | 2022-01-01 | MOLECULAR CANCER THERAPEUTICS | - | 1.01 Articolo in rivista | - |
| Patient Derived Xenografts for Genome-Driven Therapy of Osteosarcoma | Landuzzi, Lorena; Manara, Maria Cristina; Lollini, Pier-Luigi; Scotlandi, Katia | 2021-01-01 | CELLS | - | 1.01 Articolo in rivista | cells-10-00416-v2.pdf |
| Sunitinib Exerts In Vitro Immunomodulatory Activity on Sarcomas via Dendritic Cells and Synergizes With PD-1 Blockade | Ocadlikova D.; Lecciso M.; Broto J.M.; Scotlandi K.; Cavo M.; Curti A.; Palmerini E. | 2021-01-01 | FRONTIERS IN IMMUNOLOGY | - | 1.01 Articolo in rivista | frontiers in immunology.pdf |
| Circulating miR34a levels as a potential biomarker in the follow-up of Ewing sarcoma | Sciandra M.; De Feo A.; Parra A.; Landuzzi L.; Lollini P.-L.; Manara M.C.; Mattia G.; Pontecorvi ...G.; Baricordi C.; Guerzoni C.; Bazzocchi A.; Longhi A.; Scotlandi K. | 2020-01-01 | JOURNAL OF CELL COMMUNICATION AND SIGNALING | - | 1.01 Articolo in rivista | - |
| Insulin-Like Growth Factor 2 mRNA-Binding Protein 3 Modulates Aggressiveness of Ewing Sarcoma by Regulating the CD164-CXCR4 Axis | Caterina Mancarella , Giulia Caldoni, Irene Ribolsi, Alessandro Parra , Maria Cristina Manara , A...rthur M Mercurio , Andrea Morrione , Katia Scotlandi | 2020-01-01 | FRONTIERS IN ONCOLOGY | - | 1.01 Articolo in rivista | fonc-10-00994.pdf; file supplementari.zip |